Biote Corp. is a leader in the biotech industry, specializing in the development and commercialization of innovative biotherapies. With a strong focus on research and development, they aim to transform patient care and improve health outcomes. Their Class A common stock offers investors an opportunity to partake in their mission and potential for growth.
